Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Taysha Gene Therapies, Inc. (TSHA) had Weighted-Average Shares Outstanding (Diluted) of 369.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-46.64M |
|
-- |
|
-- |
|
$47.35M |
|
$-47.35M |
|
$0.71M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-46.64M |
|
$-47.35M |
|
$-47.06M |
|
369.04M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
369.04M |
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$461.43M |
|
$2.41M |
|
$9.00M |
|
$470.43M |
|
$25.98M |
|
$49.26M |
|
$57.19M |
|
$83.17M |
|
$387.27M |
|
$387.27M |
|
$387.27M |
|
325.30M |
|
| Cash Flow Statement Financials | |
$-81.30M |
|
$-3.02M |
|
$217.37M |
|
$322.53M |
|
$455.57M |
|
$133.04M |
|
$11.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.76 |
|
-- |
|
-- |
|
0.11 |
|
0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.04% |
|
-12.04% |
|
-9.91% |
|
-10.68% |
|
$1.19 |
|
$-0.22 |
|
$-0.22 |
|